WriteEdit-Grant Questions Blog

Syndicate content
Customized Customer Support for Biomedical Researchers
Updated: 6 hours 5 min ago

By: Mika 6787

Tue, 01/02/2018 - 11:17

@writedit, happy new year, I am working on the revised application for resubmission, question is how to mark the”track changes” Thanks

Categories: NIH-Funding

By: writedit

Wed, 12/20/2017 - 18:15

Thanks for sharing your intel with us. Again, congratulations, and best wishes for success with your research!

Categories: NIH-Funding

By: YJ

Wed, 12/20/2017 - 17:46

Thanks, Mine was 6th percentile. Per my recent discussion with the PO, current payline is 7the percentile for R21.

Categories: NIH-Funding

By: R21_Hopeful

Wed, 12/20/2017 - 17:37

Congratulations @YJ. Were you at 7th percentile or better for an R21?

Categories: NIH-Funding

By: writedit

Wed, 12/20/2017 - 17:11

Congratulations – you should get some of that cut back (maybe all, depending on whether it was all due to CR) once the budget passes.

Categories: NIH-Funding

By: YJ

Wed, 12/20/2017 - 17:00

FYI, I recently received an NOA of my NCI R21 application with 13% budget cut. Mine was 6%.

Categories: NIH-Funding

By: KK

Wed, 12/20/2017 - 16:44

Thanx for the answer. I sure hope the budget does get passed soon and with an increase so we could at least have the same payline as last year.

Categories: NIH-Funding

By: writedit

Wed, 12/20/2017 - 16:41

The entire NIH is operating at 90% of their FY17 appropriation, but since no IC knows the outcome of the federal budget (ie, whether they will receive the appropriation they anticipate), they are very conservative in making awards just in case something unexpected occurs and they receive a cut rather than a slight increase in funding levels. At NCI, then, awards being made during the CR would be well below the 10th percentile and probably selected based on programmatic priority as well. During this period of federal budget uncertainty, rather than ask your PO if you will be funded, you could ask if you should prepare a resubmission (or new submission).

Categories: NIH-Funding

By: KK

Wed, 12/20/2017 - 15:34

Is there any information on the 2018 NCI payline yet? What is the payline that is currently being awarded while we are still on a CR? Thanx

Categories: NIH-Funding

By: uso

Mon, 12/18/2017 - 10:51

thank you so much

Categories: NIH-Funding

By: writedit

Mon, 12/18/2017 - 10:47

You can sit tight – nothing has gone wrong, other than bureaucracy during the holiday period, when everything takes a little longer (especially with all the FY18 federal budget chaos as well). Once the grants management folks have finished preparing the awards, they still need to be signed off on. If the GMS needed any more information from you, they would have gotten in touch directly. Just be patient a little longer – no need to be worried (and congratulations!).

Categories: NIH-Funding

By: uso

Mon, 12/18/2017 - 10:03

My application for R01 funding to NHLBI received a score of 11% in June 2017. I have submitted requested JIT information, and status on era commons has switched to “pending”. The grants management specialist told me that the NOA was set to be released on 12/12/2017 but I still have not heard anything. I don’t want to keep bugging them – would you happen to have any thoughts on why there might be a delay? Thanks so much for all of the information and guidance you provide

Categories: NIH-Funding

By: writedit

Fri, 12/15/2017 - 18:07

Looking at how few awards they issue (29 current awards listed in RePORTER for all of CDC & FDA combined), I am sure there is no payline but that awards made based on score & programmatic preferences. I would suggest you contact the appropriate individual(s) at the CDC (depending on which center/program best fits your work) and the FDA for information both on whether your science would be a priority (but look closely at past awards for clues, too) and how they select applications for funding. You can find the contacts both in the PDF that SaG helpfully cited (thank you!) and at https://sbir.nih.gov/engage/ic-contacts

Categories: NIH-Funding

By: SaG

Fri, 12/15/2017 - 12:52

You can find all of the HHS topics (including CDC, FDA, NIH etc.) in this pdf. https://sbir.nih.gov/sites/default/files/2017-2_SBIR-STTR-topics.pdf

I am not sure FDA or CDC publish a payline for SBIRs. But, if anyone can find it W.E. can.

Categories: NIH-Funding

By: SBIR PI

Thu, 12/14/2017 - 22:19

Hi Writedit – do you know where I can find the CDC and FDA SBIR paylines? Also, where can I find what topics are of interest to FDA under the SBIR omnibus?

Categories: NIH-Funding

By: writedit

Thu, 12/14/2017 - 13:54

Up to you. If you need the space and will cite the same material in Significance or elsewhere, then you can focus on the story. If you are making a statement that requires a citation for credibility (whole story hinges on this work having been peer reviewed, or a series of key & perhaps not intuitively related discoveries), then that might be more important than references for accepted/known concepts/state of the science. Ditto if you want to convey your prior work has been published (to all those reviewers not assigned to read the entire proposal). Really a case-by-case judgment call on how you draft the narrative on that page.

Categories: NIH-Funding

By: Mika 6787

Thu, 12/14/2017 - 12:06

NIH RO1, Specific Aims should be cited with references or not ? thanks

Categories: NIH-Funding

By: writedit

Tue, 12/12/2017 - 11:51

NIMH probably had an internal meeting to discuss applications under consideration, pending the budget, and/or determine what could be funded under the CR. If you haven’t already, you could ask your PO now whether you should start working on a resubmission for March (or February, if an A1 application scored the 20). If he tells you to sit tight and not reapply, you have your answer.

Categories: NIH-Funding

By: K applicant

Tue, 12/12/2017 - 11:30

Received a 20 on my K resubmission to NIMH. PO has said he is optimistic, but can offer little certainty until after the budget passes, of course. He mentioned that he would likely have more information after a November 30 meeting – any idea what that meeting might be? Council isn’t until January 2018. Would it be appropriate to check in or should I sit tight and wait to hear from him?

Categories: NIH-Funding

By: writedit

Tue, 12/12/2017 - 10:42

Yes, SRG composition changes with each meeting. You can see the regular members and the years on which they will leave the study section in the main roster and check the flow of ad hoc reviewers from meeting to meeting (for prior meetings – you only get to see specific meeting rosters 30 days in advance of the review date). You can compare your current roster with your prior roster for differences to see if there were significant changes and talk with your PO about the current SRG membership. Your PO goes to meetings – yours wasn’t discussed, of course, but PO might be able to comment on whether current iteration of the panel would be receptive to seeing your application again or if you should try a different SRG (and which to try, if so).

Categories: NIH-Funding